Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats

Angélica Vega-García, Luísa Rocha, Rosalinda Guevara‐Guzmán, Christian Guerra‐Araiza, Iris A. Feria-Romero, Juan Manuel Gallardo, Teresa Neri-Gómez, José Eduardo Suárez-Santiago, Sandra Orozco‐Suárez

Current Pharmaceutical Design · 2020 · 11 citations · 58 references

Abstract

The results indicating that Magnolia officinalis is an alternative preventive treatment for early stages of epileptogenesis are encouraging.

References

58